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Abstract
Background: The aim of the present study was to determine the utility of computed tomography (CT)
and magnetic resonance imaging (MRI) anatomic mapping in the detection of biliary and vascular
anomalies prior to a living liver donor (LLD) operation.
Methods: A retrospective study of all LLD patient charts, operative and radiology reports from 1 January
2002 to 1 January 2012 was conducted. Primary post-operative outcomes assessed included mortality,
re-operation, readmission and need for endoscopic or percutaneous intervention. Sensitivity and spe-
cificity of MR and CT pre-operative screening was calculated against the gold standard of intra-operative
findings.
Results: A total of 34 donors had an average age of 38 years (range: 22–58) with a body mass index
(BMI) of 25.6 kg/m2 (range: 19.8–32.5) and a length of stay (LOS) of 10.1 days (range: 5–41). There were
no donor mortalities. Sensitivity and specificity of CT was 70.0% and 91.3%, and of MRI screening 23.1%
and 100.0%, respectively. Patients with inaccurate pre-operative CT or MRI did not have an increased risk
of complications.
Conclusions: Even although it was specific, pre-operative MR screening missed up to 77.0% of biliary
anomalies. An impeccable surgical technique remains the key in preventing biliary complications of a
living donor hepatectomy where pre-operative MRI screening is false.
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Introduction
In Canada approximately 400 liver transplants are performed
every year.1 As a result of the increasing need for organs and
limited availability, in British Columbia there is a 30% mortality
rate for those waiting on the liver transplant list.1 The use of a live
liver donation (LLD) allows the patients a faster option for trans-
plantation if a suitable donor is available.
The first LLD case series was reported in 1990 in paediatric
recipients at the University of Chicago.2 Since this landmark
study, LLD has been viewed as a valuable alternative for patients
awaiting a cadaver organ, and can be performed with low
morbidity.3–10 Even although there is a learning curve to this type
of donation, it has demonstrated outcomes superior to whole
cadaveric organs.11 Nonetheless, the greatest disadvantage of this
procedure is the risk it imposes on the donors, who ultimately
receive no physical benefit from it. Some of the most important
complications are those related to vascular and bile duct
anastomoses.9,12–21 They result in reoperations, a prolonged hos-
pital stay and the need for serial percutaneous and endoscopic
procedures.7,22–24
The evaluation of biliary and vascular anatomy of donor candi-
date livers is essential.25–29 It identifies the pattern of hepatic artery
andbile duct branching,which can affect the surgical approach and
in some cases, even preclude donation.28 Knowing the vascular and
biliary anatomy is useful in assessing the risk of complications
imposed on the donor, in determining the suitability of the liver
graft for the recipient, and in stratifying the risk of biliary and
vascular complications.30,31
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However, most previous studies performed on imaging
in living liver donors focus on the accuracy of imaging, yet
have not identified how inaccurate imaging may affect patient
outcomes.29,32,33 The purpose of this study was to evaluate the
use of computed tomography (CT) and magnetic resonance
imaging (MRI) pre-operatively in predicting biliary and vascular
anatomy as well as evaluating the role it had in post-operative
complications.
Methods
A retrospective study of all LLDs to date in British Columbia,
Canada, was conducted. Patient charts, intra-operative reports
and imaging results were reviewed on all LLDs admitted from
2002 to present for a living donor hepatectomy. Ethics approval
was obtained from our intuitional Ethics Review Board.
Inclusion criteria for LLD in British Columbia are as follows:
• The donor could be a relative, spouse, or friend.
• The blood type of the donor must be compatible with the
recipient’s.
• The donor should be in good physical and mental health.
• The donor should be between 19–60 years old.
• The decision to be a donor should be made after careful under-
standing of the procedures, and consideration of the risks and
complications involved.
Data were collected from several sources including the prospec-
tively collected British Columbia LLD Transplantation database
and hospital patient records in order to determine demographic
variables, and variables pertaining to surgical morbidity and mor-
tality and findings of routine pre-operative imaging. Surgical
reports of donor hepatectomies were reviewed to determine
patient anatomy, cholangiogram findings and the number of
ductal orifices anastomosed as well as the presence of aberrant
hepatic artery anatomy. Patients were not included who were
deemed ineligible for donation based on imaging because these
patients’ records were not available at the time of data collection.
The primary outcomes assessed included mortality and post-
operative complications of bile leak, wound infection, hernia
formation, pneumonia, line complications and venous throm-
boembolism (VTE). The length of hospital stay, need for readmis-
sion, radiological and endoscopic interventions, and reoperation
were also assessed. The length of hospital stay was defined as time
from surgery to discharge home in days. The need for readmission
was defined as admission to a hospital after first discharge after
surgery within 1 year of a donor hepatectomy.VTE was defined as
lodging of a blood clot in a pulmonary artery with subsequent
obstruction of blood supply to the lung parenchyma or the for-
mation, development or existence of a blood clot or thrombus
within the vascular system.34 Mortality was defined as 1-year
mortality and total mortality. The number of re-operations, re-
admissions, and percutaneous and endoscopic procedures on
first admission and within the first 12 months after the donor
surgery were quantified. Dindo–Clavien classification of surgical
complications was used to classify our complication rates.35
Complications requiring intervention were classified, whether it
be without (IIIa) or with general anaesthesia (IIIb) or life threat-
ening requiring intensive care unit management (IV) or involving
death (V).
Magnetic resonance cholangiography
Magnetic resonance cholangiography (MRCP) was performed
using a 1.5-T MR magnet (Magnetom Symphony; Siemens
Medical Solutions, Malvern, PA, USA) with a four-channel body
phased-array surface coil as a radiofrequency receiver. A
respiratory-triggered T2-weighted TSE sequence with T2-
weighted prospective acquisition correction (PACE) was adopted
as of 2010. The newer PACE technique was adopted as it monitors
the breathing pattern using the movements of the diaphragm to
adjust the images to minimize motion artefact. Pre-operative
MRCP were interpreted by a specialized radiologist, not aware of
the intra-operative findings. In general, the biliary anatomy was
reported using the classification published by Basaran et al.36
Computed tomography
Computed tomography screening was performed using
multidetector-row CT (LightSpeed QX/I; General Electric
Medical Systems, Milwaukee,WI, USA) with interleaved multide-
tector capability. Acquisition of the arterial phase was initiated
within 5 s after reaching enhancement of the descending aorta up
to 70HU asmeasured using a bolus-tracking technique after intra-
venous injection of 150 ml of iopromide (Ultravist 370; Schering,
Berlin, Germany) through an 18-gauge injection into a peripheral
vein using a power injector at a rate of 3 ml/s. The images were
obtained in a craniocaudal direction through the entire liver
during a single breath hold. The technical parameters included a
detector row configuration of 4 ¥ 1.25 mm, pitch of 6:1 (high-
speed mode), gantry rotation speed of 0.8 s, table speed of 15 mm
per gantry rotation (18.75 mm/s), 120 kVp and 240–300 mA. The
1.25-mm transverse sections were reconstructed at 0.625-mm
intervals using a 180° interpolation process.
Intra-operative cholangiography
Intra-operative cholangiography was performed through a 4- or
5-F catheter inserted into the cystic duct while manually injecting
10 to 20 ml of iohexol (Omnipaque, Nycomed, Princeton,
NJ, USA). Fluoroscopy was performed in anterior–posterior
orientations.
Operative procedure
Liver parenchyma was resected using a cavitronic ultrasound sur-
gical aspirator (Valley Lab Inc., Boulder, CO, USA), liga clips,
prolene sutures and unipolar electrocautery.
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Sensitivity, specificity, negative predictive
value and positive predictive value
The sensitivity and specificity of MRCP and CT mapping of the
vascular and biliary anatomy was studied. This was measured
against the gold standard of intra-operative findings as illustrated
by surgeon observations and the routinely performed intra-
operative cholangiograms.
Sensitivity was defined as a true-positive rate and specificity as
the true-negative rate of MRCP and CT in diagnosing atypical
biliary and vascular anatomy. The negative predictive value (NPV)
was calculated as the number of true negatives divided by the sum
of true-negative and false-negative tests. The positive predictive
value (PPV) was calculated as the number of true positives
divided by the sum of true-positive and false-positive tests. Accu-
racy was defined as the ratio of true tests and all tests. For analysis
purposes, a positive imaging test result was defined to be that
which identifies aberrant ductal or vascular anatomy and a true
imaging test result having congruent findings with the gold stand-
ard. Aberrant hepatic vascular and biliary anatomy was defined as
any configuration of hepatic vasculature or bile ducts that deviates
from all of the following:
1 Hepatic artery arising from the celiac trunk and branching into
left and right (classic anatomy).
2 Portal vein coming off the inferior mesenteric vein along with
the splenic vein and branching into the left and right portal
veins.
3 Common bile duct being made of double confluence from the
right and left hepatic ducts, as per the Couinaud scheme.36
For the present analysis, descriptive statistics, such as frequency,
mean, median and standard deviation were used to report patient
demographics morbidity and mortality rates. Data analysis was
performed using the STATA64™ statistical analysis software
(StataCorp., College Station, TX, USA)
Patients with incongruent findings on imaging were compared
with those who had congruent findings on imaging in terms of
their outcomes. Both linear and logistic regression was performed
with control for appropriate confounders, including age, comor-
bidities and BMI. Non-parametric tests including Fisher’s exact
and the chi-squared were used for comparison.
Results
A total of 34 donors were reviewed as 3 out of 37 donors to date
had incomplete data or were lost to follow-up. The donor hepa-
tectomies were performed by one of two surgeons at this institu-
tion. One donor was deemed a non-candidate for a donor
hepatectomy after undergoing anaesthesia and a laparotomy. The
average age was 38.2 years (range: 22–58) with a BMI of
25.6 kg/m2 (range: 19.8–32.5), rate of current smoking in two
(5.89%) and an average length of hospital stay of 9.9 days (range:
5 to 41). The average liver volume on CT was 1367.8 ml [standard
deviation (SD) 428.1]. A right hepatectomy was performed in 19
(55.9%) patients, with vascular anomalies noted in 8 (23.5%) and
biliary anomalies in 11 (32.4%) patients. A total of five (14.7%)
patients had both a vascular and a biliary anomaly. A CT scan
angiography was incorrect in identifying vascular anomalies in 7
(20.6%) and a MRI was incorrect in identifying biliary anomalies
in 8 (23.5%) of patients.
Post-operative outcomes are shown in Table 1. There were no
mortalities. A total of 18 (52.9%) had at least one complication,
with pneumonia in 9 (26.4%),VTE in 1 (2.94%), wound infection
in 3 (8.82%), bile leak in 6 (17.6%), hernia in 6 (17.6%) and
readmission in 7 (20.6%). Procedures for post-operative compli-
cations were also investigated and found to be as follows: reop-
eration on the same admission was performed in 2 (5.88%) and
within a year in 9 (26.5%), radiological drainage in 7 (20.6%) and
endoscopic retrograde cholangiopancreatography (ERCP) in 10
(29.4%) patients. The site of hepatectomy was not associated with
an increased risk of complications (Fig. 1) or with an increased
risk of anomalies and incorrect pre-operative imaging (Fig. 2).
Table 2 shows the distribution of post-operative complications
according to Dindo-Clavien classification.35
Fisher’s exact and chi-squared analysis were performed in order
to explore relationships between the presence of a vascular
anomaly, biliary anomaly or both, and the incidence of post-
operative complications. This is shown in Table 3 which illustrates
that class 3 post-operative complications were not significantly
related to patient age, BMI, smoking status, type of hepatectomy
or presence of biliary and/or vascular anomalies. As seen in
Table 4, the prevalence of biliary anomalies was 11 (32.4%) and of
vascular anomalies was 8 (23.5%). A total of 14 (41.2%) patients
had an incorrect CT and/or MRI pre-operative imaging test, or a
test result that did not match the intra-operative findings, which
Table 1 Post-operative complications
Outcome measure n %
Pneumonia 9 26.4
Bile leak 6 17.6
Hernia 6 17.6
Wound 3 8.8
VTE 1 2.9
Line complication 1 2.9
Readmission 7 20.6
Class 3 complication: 14 41.2
Re-operationa 3 8.7
ERCP 9 25.7
Radiology intervention 10 28.6
Death 0 0
Intensive care unit stay 0 0
aTwo re-operations were performed on initial admission, one surgery
within the 1st year.
VTE, venous thromboembolism; ERCP, endoscopic retrograde
cholangiopancreatography.
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were the gold standard, as previously described. Table 5 shows the
sensitivity and specificity of CT mapping of vascular anomalies to
be 70% and 91%, respectively. On the other hand, the sensitivity
and specificity of MRI mapping for biliary anomalies was 23%
and 100%, respectively. Neither incorrect MRI imaging nor the
presence of a biliary anomaly had any impact on post-operative
complications, which is shown in Table 6.
In this study, none of the patients with suspicious pre-operative
MRCPs had an ERCP. None of the patients had pre-operative
ERCP before undergoing the LLD procedure. Out of 10 patients
who underwent post-operative ERCP, 8 were for the treatment of
bile leaks with sphincterotomy and/or stent placement. One ERCP
showed a normal biliary tree but significant bile reflux and Heli-
cobacter pylori on biopsies from the duodenum, whereas one
ERCP report could not be obtained. Reoperations were performed
in a total of 9 (26.4%) patients as shown in Table 7. Two patients
had reoperation on the same admission, one for a vascular throm-
bosis of the segment IV arterial branch and the second for wound
dehiscence. Seven surgeries were performed after the initial
admission, two for bile duct stenosis and others for hernia repair.
Discussion
In this study of 34 living liver donors and the effects of anatomic
mapping on patient outcomes, we found that CT mapping of
vascular anomalies was both sensitive and specific, whereasMRCP
had a low sensitivity in detecting biliary anomalies in spite of its
high specificity. Regardless of the low MRCP sensitivity in this
study, the presence of vascular and biliary anomalies or of an
incorrect pre-operative CT or MRCP was not associated with an
increase in post-operative complications.
The accuracy of biliary and vascular mapping in LLD candi-
dates has shown good results in the past.30,32,37–39 The sensitivity of
biliary mapping with MR has been found to range from 71.4 to
100%, and specificity from 77.8 to 100%.40 Similarly to Byun
et al.,38 it was found that vascular mapping with CT angiography
was a sensitive and specific test. Importantly, our findings showed
that MRCP was only 23% specific in identifying biliary anomalies
which has not been the case in previous similar studies in this
patient population.37
It is of some concern that pre-operative evaluations MRCP
were not more specific. The fact that we used formal radiological
reports might explain this, as they do not reflect the informal
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Figure 1 Incidence of post-operative living liver donor (LLD) morbid-
ity according to graft type, n = 34. Note: after Fisher's exact test was
performed, the side of the hepatectomy was not significantly asso-
ciated with any of the types of complication
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Figure 2 Incidence of anomalies and incorrect imaging according to
graft type, n = 34. Note: after Fisher's exact test was performed, the
side of the hepatectomy was not significantly associated with the
incidence of anomalies or incorrect pre-operative imaging
Table 2 Post-operative complications in donors according to Dindo–Clavien classification,35 n = 34
Grade n %
Grade III
Requiring surgical, endoscopic or radiological intervention
14 41.2
IIIa Radiology intervention 10 28.6
ERCP 9 25.7
IIIb Re-operationa 3 8.7
Grade IV
Life-threatening complication (including CNS complications)a requiring IC/ICU management
0 0
Grade I
Death of a patient
0 0
aTwo re-operations were performed on initial admission, one surgery within the 1st year.
ERCP, endoscopic retrograde cholangiopancreatography; CNS, central nervous system; ICU, intensive care unit.
HPB 735
HPB 2013, 15, 732–739 © 2013 International Hepato-Pancreato-Biliary Association
imaging reviews that occur between the surgeon and the radiolo-
gist. In addition, the present facility may not always have a dedi-
cated ‘abdominal radiologist’ reviewing the images, particularly if
they are taken at a smaller hospital pilot site. Hence, reinterpreting
images with this in mind may have improved sensitivity and spe-
cificity results. Some of the MRCPs that were performed prior to
2010 would have been suboptimal as a result of the older scanners,
which are often difficult to interpret based on patient factors such
as breathing artefact. A newer technique MRCP that utilizes a
respiratory-navigator triggered T2-weighted turbo spin-echo
(TSE) sequence with a prospective acquisition correction (PSE)
technique is now being used which has been found to have supe-
rior sensitivity and specificity to the aforementioned older tech-
nique.37 The present institution radiologists routinely use the
Basaran criteria37 when reporting biliary anatomy. However, some
of pre-operative MRCP and CT scans were performed outside of
our institution, and not consistently reported in this fashion,
Table 3 Patient characteristics and post-operative complications requiring endoscopic, radiological or an operative intervention
Variable Level ERCP Fisher's
P-value
Radiological
intervention
Fisher's
P-value
Re-operation* Fisher's
P-value
Overall 10 11 9
Age (years)
1st quartile (22–32) 2 0.125 8 0.573 2 1.000
2nd quartile (33–36) 1 5 2
3rd quartile (38–47) 6 5 3
4th quartile (48–58) 1 5 2
Gender 0.275 0.594 0.163
Male 4 6 3
Female 6 5 6
BMI (kg/m2) 0.787 0.409 0.586
1st quartile (<23) 4 3 2
2nd quartile (23–25.3) 1 2 1
3rd quartile (25.4–28.8) 3 5 4
4th quartile (28.9–32.5) 2 1 2
Procedure 0.529 0.400 0.640
Right hepatectomy 6 7 5
Left hepatectomy 4 4 4
Smoking status 0.080 0.098
Current smoker 2 2 2.9
Non current smoker 8 9
Relationship 0.322 0.223 0.560
Related 7 8 5
Unrelated 3 3 4
Biliary anomaly 0.409 0.511 0.625
Present 4 4 3
Classic 6 7 6
Vascular anomaly 0.539 0.158 0.277
Present 2 1 1
Classic 8 10 8
*Two reoperations were performed on initial admission, one surgery within the 1st year.
BMI, body mass index.
Table 4 Prevalence of anomalies and accuracy of magnetic reso-
nance imaging (MRI) and computed tomography (CT) mapping in
study patients
Anatomic mapping for anomalies N %
Biliary anomaly found in OR 11 32.4
Vascular anomaly found in OR 8 23.5
Patients whose MRI/CT imaging was
inaccurate pre-operative
14 41.2
Wrong MR 12 35.3
False negative 10
False positive 0
Wrong CT 3 8.8
False negative 3
False positive 2
Missing data on CT and MRI in a total of two patients.
OR, operating room.
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which likely contributed to the lower sensitivity of biliary anomaly
reports.
Regardless of the low MRCP sensitivity in this study, the
presence of vascular or biliary anomalies or of an incorrect
pre-operative imaging was not associated with an increased
peri-operative morbidity, including Dindo–Clavien Grade III
complications.35 One explanation for this observation is that intra-
operative cholangiogramuse and superb surgical technique are the
most significant factors in optimizing surgical outcomes for the
donors. Similarly to us, Marcos et al.41 reviewed the effects of
anatomic variations on donor right hepatectomy outcomes. They
reviewed the surgical approaches todonor right hepatectomies that
allow for a safe procedure without donor complications and
complex reconstruction. Even although they did not address the
importance of imaging, they found that surgical technique alone
and a thoughtful approach to hilar dissection can result inminimal
morbidity for donors. Their study supports the present findings
that thehigh technical ability,attention todetail andhigh standards
Table 5 Sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of computed tomography (CT)
angiogram mapping of vascular anomalies and magnetic resonance cholangiography (MRCP) mapping of biliary anomalies against the gold
standard of intra-operative findings
Sensitivity (%) Specificity (%) Accuracy (%) PPV (%) NPV (%)
CT scan 70.0 91.3 84.8 77.8 87.5
MRCP 23.1 100.0 67.7 100.0 64.3
CT, computed tomography; PPV, positive predictive value; NPV, negative predictive value.
Table 6 Post-operative complications in patients with incorrect pre-operative magnetic resonance imaging (MRI) mapping and anomalous
biliary anatomy
Variable Level Wrong
MRI
Odds
ratio
Confidence
Interval
Fisher's
exact
P-value
Biliary
Anomaly
Odds
ratio
Confidence
interval
Fisher's
exact
P-value
Pneumonia 1.5 0.23,9.30 0.454 1.06 0.14,6.71 0.625
Yes 4 3
No 8 8
VTE 0 0 0.625 0 0 0.677
Yes 0 0
No 12 11
Wound infection 3.8 0.17,235.71 0.311 4.89 0.22,301.17 0.239
Yes 2 2
No 10 9
Hernia 0.8 0.062,6.91 0.601 2.5 0.27,22.30 0.288
Yes 2 3
No 10 8
Readmission 0.6 0.049,4.70 0.465 0.8 0.07,6.24 0.596
Yes 2 2
No 10 9
Class 3 complication 6 1.85 0.34,10.08 0.320 5 1.296 0.23,6.93 0.506
Reoperation* 3 0.778 0.10,4.92 0.546 3 1.063 0.14,6.71 0.625
ERCP 5 2.858 0.44,18.86 0.180 4 1.619 0.25,9.53 0.409
Radiology intervention 4 1.167 0.18,6.82 0.573 4 1.306 0.21,7.40 0.511
All confidence intervals are 95%.
Fisher's exact value is one-sided.
VTE, venous thromboembolism.
Table 7 Reoperations in living liver donors, n = 34
Outcome measure n %
Hernia repair 7 20.6
Repeat biliary reconstruction 1 2.9
Repair of bile duct stricture 1 2.9
Haemostasis 0 0
Liver transplantation 0 0
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of success are very important in minimizing donor hepatectomy
morbidity.
As shown in previous studies of outcomes of complex sur-
gical procedures and hospital volume, continuous outcome-
measurement and collaborative quality improvement initiatives
are important in bettering surgical patient care.42 This study illus-
trates that over time, with increased surgical and radiologist
expertise can be built, along with new system policies and new
technologies that result in patient outcomes equivalent to large
volume centres. The present results and experience can be valu-
able to other institutions with smaller LLD programmes in setting
up their imaging facilities, building relationships between sur-
geons and radiologists, and establishing surgical approaches for
potential donors with anomalous anatomy.
In summary, our institutional experience with the first 10 years
of LLD demonstrates that CT and MR anatomic mapping contin-
ues to be crucial in work up LLD candidates, and complementary
to intra-operative cholangiography and surgical findings. A living
donor hepatectomy can be safely performed in donors with biliary
and vascular anomalies and that impeccable surgical technique,
and surgeon–radiologist collaboration remains key in preventing
biliary complications where pre-operative CT and MR anatomic
mapping is false in order to minimize the morbidity of living
donor hepatectomies.
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